Effect of lipoproteins on mesangial cell proliferation

Kidney International, Supplement

Volumn 56, Issue 71, 1999, Pages

  Nishida, Yoji ^a   Oda, Hiroaki ^a   Yorioka, Noriaki ^a  

^a HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Atherosclerosis; Cytokine; HDL; IDL; LDL; Triglycerides; VLDL

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN; CYTOKINE; INTERLEUKIN 6; INTERMEDIATE DENSITY LIPOPROTEIN; PLATELET DERIVED GROWTH FACTOR; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL CULTURE; CELL DIVISION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; HUMAN; MESANGIUM; ATHEROSCLEROSIS; CELL ACTIVATION; CELL COUNT; CELL DAMAGE; CELL GROWTH; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN CELL; MESANGIUM CELL; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS;

CELL DIVISION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GLOMERULAR MESANGIUM; HUMANS; LIPOPROTEINS; LIPOPROTEINS, HDL; LIPOPROTEINS, LDL; LIPOPROTEINS, VLDL;

EID: 0033043635     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. MOORHEAD JF, CHAN MK, EL-NAHAS M, VARGHESE Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease. Lancet 2:1309-1311, 1982
2. KEANE WF, MULCAHY WS, KASISKE BL, KIM Y, O'DONNELL MP: Hyperlipidemia and progressive renal disease. Kidney Int 39(Suppl 31):S41-S48, 1991
3. DIAMOND JR: Analogous pathobiologic mechanisms in glomerulosclerosis and atherosclerosis. Kidney Int 39(SuppI 31):S29-S34, 1991
4. JOLES JA, VAN GOOR H, VAN DER HORST MLC, VAN TOL A, ELEMA JD, KOOMANS HA: High lipid levels in very low density lipoprotein and intermediate density lipoprotein may cause proteinuria and glomerulosclerosis in aging female analbuminemic rats. Lab Invest 73:912-921, 1995
5. GOLDSTEIN JL, BASU SK, BROWN MS: Receptor-mediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol 98:241-261, 1983
6. NISHIDA Y, YORIOKA N, ODA H, YAMAKIDO M: Effect of lipoproteins on cultured human mesangial cells. Am J Kidney Dis 29:919-930, 1997
7. SHARMA P, REDDY K, FRANKI N, SANWAL V, SANKARAN R, AHUJA TS, GIBBONS N, MATTANA J, SINGHAL PC: Native and oxidized low density lipoproteins modulate mesangial cell apoptosis. Kidney Int 50:1604-1611, 1996
8. TAKAHASHI S, KAWARABAYASHI Y, NAKAI T, SAKAI J, YAMAMOTO T: Rabbit very low density lipoprotein receptor: A low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89:9252-9256, 1992
9. CORITSIDIS G, RIFICI V, GUPTA S, RIE J, SHAN Z, NEUGARTEN J, SCHLONDORFF D: Preferential binding of oxidized LDL to rat glomeruli in vivo and cultured mesangial cells in vitro. Kidney Int 39:858-866, 1991
10. NEVEROV NI, KAYSEN GA, NUCCITELLI R, WEISS RH: HDL causes mesangial cell mitogenesis through a tyrosine kinase-dependent receptor mechanism. J Am Soc Nephrol 8:1247-1256, 1997